Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

v3.19.3
Accrued Expenses
6 Months Ended
Sep. 30, 2019
Payables and Accruals [Abstract]  
Accrued Expenses

Accrued expenses are composed of the following at September 30, 2019 and March 31, 2019:

 

     September 30,      March 31,  
     2019      2019  
             
 Accrued expenses for AV-101, PH94B, and PH10            
      clinical trial, development and related expenses   $ 2,080,700     $ 1,067,600  
 Accrued compensation     -       439,200  
 Accrued professional services     127,600       172,100  
 All other     7,200       6,700  
    $ 2,215,500     $ 1,685,600